Objective To compare the content of saponin in Bark of Silktree Albizziae and Bark of Silktree Albizziae kaldora derived from different collection periods.Method Spectrophotometry was used to determine the contents of saponin.Result The contents of saponin in one-year Bark of Silktree Albizziae is different from two-year Bark of Silktree Albizziae(P0.05).The contents of saponin in multi-year Bark of Silktree Albizziae is different from multi-year Bark of Silktree Albizziae kaldora(P

OBJECTIVE: To discuss the transnational management strategy of traditional Chinese medicine(TCM) enterprises in China.METHODS: The actuality of the transnational management of TCM enterprises and the main difficulties encountered by them were analyzed.RESULTS: The problems such as foreigners' different opinions on TCM,the laws,intellectual property rights and technology faced by TCM enterprises hindered the practice of the strategy of transnational management.CONCLUSION: The TCM enterprises in China should rely on special advantages in TCM to cultivate the ownership advantages,regional advantage and internalization advantage so as to effectuate transnational management.

Pathological myopia(PM)is one of the global leading causes of blindness because of its severe optic complications.Previous researches implicated that hereditary factors play crucial roles in the pathogenesis of PM,and plenty molecular genetic studies,such as gene mapping and candidate gene screening,have been done to identify gene loci linked to PM.The newest advances in molecular genetic study on pathological myopia relevant gene loci were reviewed,including non-syndrome PM and system disease associated with PM.

This paper introduced the risk communication principles made by WHO including: establishing trust, releasing information betimes, keeping transparent , listening to the public opinions and involving them in etc.Seven steps to make a two -way and interactive communication are also put up on that basis .It covers infor-ming the medial information and comforting patients ’ anxiety.In addition, the strategies of informing the patients of high-risk medical issues or low -risk medical issues and good or bad news are also mentioned .

Exterior-and interior-meridian acupoints were used, mainly by selection of local acupoints along meridian. According to the state of disease, electroacupuncture and acupoint injection were combined to treat brachial plexus injury. Among 12 patients, 6 cases were basically cured, 4 cases got effectiveness and 2 cases had no effectiveness. The therapeutic effect of exterior- and interior-meridian acupoints in brachial plexus injury was satisfactory.

Objective To compare the content of total flavonoids in Herba Scutellarlae Barbatae derived from different places.Method UV metric method was used to determine the contents of total flavonoids of Herba Scutellarlae Barbatae from different regions.Result The contents of total flavonoids in Herba Scutellariae Barbatae derived from Nantong Jiangsu,Juaoling Guangdong,Lixin Anhui,Huaning Hunan, Mojiang Yunnan,Yongding Fujian,Nanchang Jiangxi,Longsheng Guangxi,Honghu Hubei and Qingyuan Zhejiang were 4.16%,3.55%,2.89%,2.78%,2.41%,2.22%,2.16%,1.98%,1.61% and 1.51%,respectively. Conclusion The content of total flavonoids in Herba Scutellariae Barbatae from different places is quite different,and the highest is the one from Nantong Jiangsu.

AIM: To observe the adverse effect and clinical efficiency of Y-shape plate internal fixation for treating comminuted distal humeral fracture. METHODS: A retrospective analysis was conducted in 18 patients with the comminuted distal humeral fracture,who were admitted in the First Affiliated Hospital of Nanyang Medical College from January 2003 to December 2006. All patients were treated with Y-shape stainless steel or Ti-alloy plate in 3-7 holes,then the response of materials and host was observed. The curative efficiency was assayed with Cassebaum score,and the healing of fractures was detected with X-ray film. During follow-ups,the pain and joint motion were observed. RESULTS: The mean operational time was 134 minutes,the mean value of intraoperative blood loss was 172 mL,and all the incisions were healed well. All the patients were followed up for 6 months,and the mean time for the fracture healing was 14 weeks. One case appeared delayed healing in the resection lesion,and Kirschner's wire was loosened in 2 cases. There was no infection,local inflammatory reaction or rejection reaction occurred. Among 18 patients,11 got excellent results,4 good,2 fair,1 poor,and the rate of excellent and good efficiency was 83.3%. CONCLUSION: Y-shape plate after implantation shows good biocompatibility with the human body,with the manifestations of good reduction of comminuted distal humeral fracture,firm internal fixation,and satisfactory functional recovery of elbow joint.

Acute myeloid leukemia is a disease of malignant clone of the hematopoietic stem cell.The abnormity of molecular biology plays an important role in the pathogenesis of acute myeloid leukemia.More and more molecular abnormalities provide the basis of prognostic evaluation and target therapy.

Hematopoietic stem cell transplantation (HSCT) has become the frontline therapy for patients with multiple myeloma (MM), and for young patients with primary MM, early autologous stem cell transplantation (ASCT) is a standard treatment. In the era of novel drugs, the application of new pharmaceutics in the consolidation and maintenance therapy before and after HSCT can improve the efficacy of HSCT. The novel agents pose a challenge to the status of HSCT in relapsed and refractory myeloma. This article summarizes the recent clinical studies of HSCT in the era of novel agents to clarify the role of HSCT in treatment of MM.

OBJECTIVE: To promote Chinese pharmaceutical enterprises to understand their social responsibility clearly and to fulfill it actively.METHODS: The category of social responsibility of pharmaceutical enterprises was analyzed as well as the main approaches to perform corporate social responsibility.RESULTS: Chinese pharmaceutical enterprises should figure out their responsibility to consumers,employees,investors,society,community and other stakeholders.In recent years,the approaches to perform social responsibility based on force system of law and regulations and the improvement of enterprises' consciousness.These are unfavorable to Chinese pharmaceutical enterprises to undertake social responsibility actively.CONCLUSION: There are two approaches to promote Chinese pharmaceutical enterprises to perform their social responsibility,which are external supervision and internal governance.